Alkermes Pathways Research Awards supports research of central nervous system disorders and addiction

About Pathways

With millions of people impacted by central nervous system (CNS) disorders, more research is urgently needed to bring relief to those who are suffering. The ALKERMES PATHWAYS RESEARCH AWARDSSM program is designed to support the next generation of researchers who are working on the front-lines to advance our understanding and awareness of CNS disorders, including addiction.

Open to early career investigators committed to advancing research in substance use disorders (SUDs), the annual Pathways program provides funding for up to four research projects with an individual grant amount of up to $100,000 per project.

Recipients are selected by an independent review committee through a competitive review process and research is funded by Alkermes.

2018 Pathways Research Awards

In its inaugural year (2018), the Pathways program will support projects focused on SUD, a public health crisis.

With an estimated 1 in 7 people in the United States developing a SUDs in their lifetime, and related mortality rates rising rapidly, there is an urgent need to discover innovative approaches to improve prevention, increase understanding, advance treatment, and enhance public awareness of SUDs.

Key Dates

  • Application Process Open – May 4, 2018
  • Application Deadline – August 5, 2018
  • Notification of Review Committee Decision – Q4 2018
  • Awardee Reception – Q1 2019


The 2018 areas of scientific interest are:

  • Substance use disorder treatment, management and prevention
  • Substance use disorder and its complications in special populations
  • Basic, clinical, and translational research related to substance use disorders
  • Health economics outcomes research relating to substance use disorders

This grant is for investigators who are in the early stages of their career; specifically, they may be the recipient of a career development (K) award or other mentored research grant, but not a funded R01 grant or equivalent at time of application.

Researchers with an academic position above assistant professor are not eligible.

Pathways program grants will be awarded to junior investigators who have demonstrated their commitment to helping people living with SUDs. Eligible applicants must meet the following criteria:

  • Have an MD, PhD, or equivalent
  • Affiliated with a medical or research center within the United States at the time of application
  • Within 5 years of initial academic appointment (i.e. assistant professor) or current post-doctoral fellow
  • Research focuses primarily on furthering knowledge of SUDs
  • Have a research mentor with extensive experience in the field of SUDs
  • Have not received an NIH R01 grant at the time of award
  • Able to complete the proposed research within 2 years
  • Citizen or permanent resident of the United States or hold a temporary non-immigrant visa that is valid for the duration of the 2-year grant period

Selection Criteria

All applications will be formally reviewed by, and only by, an independent review committee, comprised of prominent researchers in the field. The review committee has final responsibility for selection of Awardees. When the Review Committee evaluates a proposal, they will consider criteria, including but not limited to:

  • Overall impact
  • Scoring based on NIH K22 grant review criteria, including the following points:
    • Candidate
    • Mentor
    • Environment and Institutional commitment to the applicant
    • Research Plan
    • Budget

2019 Pathways Research Awards

Thank you for your interest in the ALKERMES PATHWAYS RESEARCH AWARDSSM. Applications for the 2018 awards are now closed.

Please check back for information regarding the 2019 program.


Please contact